Terns Pharmaceuticals shareholders elect Kindler and Burroughs as directors; ratify Ernst & Young as auditor

Terns Pharmaceuticals, Inc.

Jeffrey Kindler elected with 45,958,352 votes for, 6,735,358 withheld, 5,131,121 broker non-votes.
Amy Burroughs elected with 52,570,019 votes for, 123,691 withheld, 5,131,121 broker non-votes.
Ernst & Young ratified as independent auditor for FY2024 with 57,570,954 for, 23,950 against, 229,927 abstentions.
Annual Meeting held June 10, 2024; 64,674,780 shares outstanding and entitled to vote as of record date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.